Diabeloop
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
17 Rue Félix Esclangon, Grenoble, Auverg...Website
www.diabeloop.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Diabeloop
Diabeloop's mission: to relieve people living with Type 1 diabetes from 100+ daily therapeutic decisions and reduce their heavy mental burden. Initially conceived from a medical research project, Diabeloop was created in 2015 by Dr. Guillaume Charpentier, now Chief Medical Officer, and Erik Huneker who has co-managed the company with Marc Julien since 2016. This complementary management team works with experienced partners such as French technology research key-player CEA-Leti.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Diabeloop your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Diabeloop has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Diabeloop launches new products
Click to see if Diabeloop had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Diabeloop
Check out if Diabeloop is spiking on competitors!
Funding: Get notified immidiatlly once Diabeloop has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Diabeloop recently announced quarterly report
Diabeloop, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Diabeloop as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Diabeloop is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Diabeloop is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Diabeloop.
Diabeloop financials insights
Gather financial insights about Diabeloop, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$15.8M
Unspecified
$16.3M
2019
Series B
$34M
2022
Series C
$75M
Diabeloop Tech Stack
A closer look at the technologies used by Diabeloop
See more technologies
Diabeloop News & Media
Diabeloop Announces Collaboration With Novo Nordisk to Pursue Its Interoperability Strategy With Connected Insulin Pens
A dedicated clinical program will assess the efficacy of the combined technologiesDiabeloop: Launch of a Multi-Country Clinical Study in Adolescents and Young Adults With T1D
Unannounced Meal Management Efficacy Key to a Better Quality of Life for People with Diabetes Unannounced Meal Management Efficacy Key to a Better Quality of Life for People with DiabetesDiabeloop and EOFlow Partner to Offer a Wearable AID With a Smartphone App
Co-developing a dedicated smartphone app that controls the AID system. European market should be first to launch. Expanding product lineups and business.12-month real-world achievements for Diabeloop's AID
4 million (1) hours of hypoglycemia avoided; Trust in the algorithm leads to fewer meal declarations; Users report a significantly reduced mental load 4 million (1) hours of hypoglycemia avoided; Trust in the algorithm leads to fewer meal declarations; Users report a significantly reduced mental load
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Diabeloop
Sign Up For FreeTo access detailed company insights
Diabeloop's mission: to relieve people living with Type 1 diabetes from 100+ daily therapeutic decisions and reduce their heavy mental burden. Initially conceived from a medical research project, Diabeloop was created in 2015 by Dr. Guillaume Charpentier, now Chief Medical Officer, and Erik Huneker who has co-managed the company with Marc Julien si... Read More
